H5N1 vaccines have been previously licensed, and millions are in the national stockpile. But even with the news of the ...

Moderna continues to cut costs, which could raise questions about the vaccine playbook used during the Covid-19 pandemic.

Stock photo of a syringe. Experts are urging the Biden administration to approve a vaccine for the H5N1 bird flu virus. Stock photo of a syringe. Experts are urging the Biden administration to ...

Although a candidate bird flu vaccine has not yet been made commercially available, medical experts advise that people should get it once it is. Dr. Linda Yancey, an expert in infectious ...

Avian, or bird, flu continues to spread across the United States, mostly at poultry and cattle farms. Poultry farmers and ...

Last week’s newsletter on the Biden administration’s refusal to approve updated bird flu vaccines before the president left office prompted many reader questions, which I wanted to address here.

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...

There is currently no vaccine for bird flu, but the U.S. Department of Health and Human Services recently announced $590 million in funding for Moderna to expedite the development of an mRNA ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...